Taylor, Clifton Ray – Trademark Portfolio

Entity Type: 01

Taylor, Clifton Ray holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include TENACIOUS and CLEAR CALM & OPEN. The owner is based in Houston, TX.

7114 Halfpenny Road

Houston, TX 770953212

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Taylor, Clifton Ray's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Taylor, Clifton Ray have?

Taylor, Clifton Ray has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Taylor, Clifton Ray file in?

Taylor, Clifton Ray files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 41 (Education & Entertainment). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Taylor, Clifton Ray's most well-known trademarks?

Taylor, Clifton Ray's registered trademark portfolio includes well-known marks such as TENACIOUS and CLEAR CALM & OPEN. These are among 2 currently registered trademarks in the portfolio.

What is Taylor, Clifton Ray's trademark registration success rate?

Taylor, Clifton Ray has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.